Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study (Q73358732)
Jump to navigation
Jump to search
scientific article published on 01 January 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study |
scientific article published on 01 January 2000 |
Statements
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study (English)
W M Stadler
N J Vogelzang
R Amato
J Sosman
D Taber